Linkage Projects - Grant ID: LP110200126

Funding Activity

Website
http://dataportal.arc.gov.au/NCGP/Web/Grant/Grant/LP110200126

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Targeting the delivery of cytotoxic agents to tumour cells using novel minicells as drug delivery vehicles and engineered, bispecific antibodies. Cancer persists as a major cause of morbidity and mortality globally. A major problem is the non-specific action of drugs used for treatment. The minicell is a drug delivery vehicle, capable of packaging a variety of drugs. The project will develop tumour-specific antibodies that will target minicells to tumours, improving cancer survival rates.

Funded Activity Details

Start Date: 03-05-2012

End Date: 02-05-2015

Funding Scheme: Linkage Projects

Funding Amount: $352,000.00

Funder: Australian Research Council

Research Topics

ANZSRC Field of Research (FoR)

Medical Biotechnology | Chemotherapy | Medical Molecular Engineering of Nucleic Acids and Proteins | Tumour Immunology

ANZSRC Socio-Economic Objective (SEO)

Cancer and Related Disorders | Expanding Knowledge in the Biological Sciences | Expanding Knowledge in the Medical and Health Sciences |

Other Keywords

Cancer and Related Disorders | Chemotherapy | Expanding Knowledge in the Biological Sciences | Expanding Knowledge in the Medical and Health Sciences | Medical Biotechnology | Medical Molecular Engineering of Nucleic Acids and Proteins | Tumour Immunology

Related Links